PharmacoEconomics & Outcomes News 784, p13 - 12 Aug 2017 Drug prices lower from online Canadian pharmacies than in US The prices of prescription drugs for Medicare Part D (MPD) beneficiaries appear to be lower from online Canadian pharmacies than in the US, according to findings of a cost analysis published in Clinical Drug Investigation. This study compared US prices for the top 100 Medicare prescription drugs which can be legally imported into the US with prices for the same drugs from Canadian online pharmacies. Cost was assessed for a generic drug unless only a brand-name drug was available. Differences in average annual costs between four MPD plans and three Canadian online pharmacies were assessed for 78 of the top Medicare drugs, from a patient perspective. Prices from Canadian online pharmacies were lower than MPD prices for 97.4% of the prescription drugs assessed; price differences ranged from –22.07% to –88.23% (mean –73.71% (p<0.0001). The majority of drugs which could be purchased from Canadian online pharmacies were for heart health/blood pressure control. "Our analysis showed that the majority of top 100 Medicare prescription drugs, with the exclusion of biologics and controlled substances, could be purchased at significantly lower costs from Canadian online pharmacies when compared to Medicare beneficiaries’ potential expenses. We also concluded that patients taking up to four chronic medications from the top 100 Medicare drugs treating airway obstruction, arthritis/pain, bladder health, diabetes, dyslipidemia, eye health, gastro-esophageal reflux disease, heart and hypertension, or certain mental and women’s health conditions, could benefit from lower drug costs from Canadian online pharmacies," said the authors. Kim SH, et al. Prescription Drug Price Paradox: Cost Analysis of Canadian Online Pharmacies versus US Medicare Beneficiaries for the Top 100 Drugs. Clinical Drug Investigation : 22 Jul 2017. Available from: URL: http://doi.org/10.1007/ s40261-017-0556-6 803261754 1173-5503/17/0784-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 12 Aug 2017 No. 784
PharmacoEconomics & Outcomes News – Springer Journals
Published: Aug 12, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera